Skip to main content
Clinical Trials/NL-OMON56914
NL-OMON56914Not yet recruitingNot Applicable

Capillary Olanzapine Sampling Method validatiOn Study - COSMOS

Maasstadziekenhuis0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • - Age 18 to 64
  • - Treated with olanzapine
  • - Signed informed consent

Exclusion Criteria

  • - Co-medication: lithium
  • - Unable to draw blood samples for study purposes
  • - If the clinician considers the patient to be mentally incompetent in decision

Investigators

Sponsor
Maasstadziekenhuis

Similar Trials